E.C. van Dalen MD PhD publications

foto

Publications MD PhD E.C. van Dalen

Position
Associate Professor
Main activities
Education, Research
Specialisation
Clinical Epidemiology
Focus of research

Systematic reviews in the field of Paediatric Oncology; especially Cochrane reviews (Cochrane Childhood Cancer Group)

Late effects of childhood cancer treatment; especially cardiotoxicity

2021

  • Goldkuhle Marius, Bender Ralf, Akl Elie A., van Dalen Elvira C., Nevitt Sarah, Mustafa Reem A., Guyatt Gordon H., Trivella Marialene, Djulbegovic Benjamin, Schünemann Holger, Cinquini Michela, Kreuzberger Nina, Skoetz Nicole GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies Journal of clinical epidemiology 2021;129:126-137 [PubMed]
  • Feijen Elizabeth Arnoldina Maria, van Dalen Elvira C., van der Pal Heleen J. H., Reulen Raoul C., Winter David L., Keuhni Claudia E., Morsellino Vera, Alessi Daniela, Allodji Rodrigue S., Byrne Julliana, Bardi Edit, Jakab Zsuzsanna, Grabow Desiree, Garwicz Stanislaw, Haddy Nadia, Jankovic Momcilo, Kaatsch Peter, Levitt Gill A., Ronckers Cecile M., Schindera Christina, Skinner Roderick, Zalatel Lorna, Hjorth Lars, Tissing Wim J. E., de Vathaire Florent, Hawkins Mike M., Kremer Leontien C. M. Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: A PanCareSurFup study Heart (British Cardiac Society) 2021;107 (1):33-40 [PubMed]

2020

  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Different infusion durations for preventing platinum-induced hearing loss in children with cancer: Version published: 21 January 2020 Cochrane database of systematic reviews (Online) 2020;2020 (1) [PubMed]
  • Verbruggen Lisanne C., Wang Yuehan, Armenian Saro H., Ehrhardt Matthew J., van der Pal Helena J. H., van Dalen Elvira C., van As Jorrit W., Bardi Edit, Baust Katja, Berger Claire, Castagnola Elio, Devine Katie A., Gebauer Judith, Marchak Jordan Gilleland, Glaser Adam W., Groll Andreas H., Haeusler Gabrielle M., den Hartogh Jaap, Haupt Riccardo, Hjorth Lars, Kato Miho, Kepák Tomáš, Koopman Maria M. W., Langer Thorsten, Maeda Miho, Michel Gisela, Muraca Monica, Nathan Paul C., van den Oever Selina R., Pavasovic Vesna, Sato Satomi, Schulte Fiona, Sung Lillian, Tissing Wim, Uyttebroeck Anne, Mulder Renée L., Kuehni Claudia, Skinner Roderick, Hudson Melissa M., Kremer Leontien C. M. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group Pediatric blood & cancer 2020;67 (12) [PubMed]

2019

  • Peinemann Frank, van Dalen Elvira C., Enk Heike, Tytgat Godelieve A. M. Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation Cochrane database of systematic reviews (Online) 2019;2019 (4) [PubMed]
  • Brennan-Jones Christopher G., McMahen Courtney, van Dalen Elvira C. Cochrane corner: platinum-induced hearing loss after treatment for childhood cancer International journal of audiology 2019;58 (4):181-184 [PubMed]
  • Feijen Elizabeth A. M., Leisenring Wendy M., Stratton Kayla L., Ness Kirsten K., van der Pal Helena J. H., van Dalen Elvira C., Armstrong Gregory T., Aune Gregory J., Green Daniel M., Hudson Melissa M., Loonen Jacqueline, Oeffinger Kevin C., Robison Leslie L., Yasui Yutaka, Kremer Leontien C. M., Chow Eric J. Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity JAMA oncology 2019;5 (6):864-871 [PubMed]
  • Skoetz Nicole, Goldkuhle Marius, van Dalen Elvira C., Akl Elie A., Trivella Marialena, Mustafa Reem A., Nowak Artur, Dahm Philipp, Schünemann Holger, Bender Ralf GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles Journal of clinical epidemiology 2019 [PubMed]
  • Mulder Renée L., Bresters Dorine, van den Hof Malon, Koot Bart G. P., Castellino Sharon M., Loke Yoon Kong K., Post Piet N., Postma Aleida, Sznyi L. szló P., Levitt Gill A., Bardi Edit, Skinner Roderick, van Dalen Elvira C. Hepatic late adverse effects after antineoplastic treatment for childhood cancer Cochrane database of systematic reviews (Online) 2019;4 (4):CD008205 [PubMed]
  • Loeffen Erik A. H., Stinson Jennifer N., Birnie Kathryn A., van Dijk Monique, Kulkarni Ketan, Rijsdijk Mienke, Font-Gonzalez Anna, Dupuis L. Lee, van Dalen Elvira C., Mulder Renée L., Campbell Fiona, Tissing Wim J. E., van de Wetering Marianne D., Gibson Faith Measurement properties of instruments to assess pain in children and adolescents with cancer: a systematic review protocol Systematic reviews 2019;8 (1):33 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer Cochrane database of systematic reviews (Online) 2019;5 (5):CD009219 [PubMed]
  • Skoetz Nicole, Goldkuhle Marius, Weigl Aaron, Dwan Kerry, Labonté Valérie, Dahm Philipp, Meerpohl Joerg J., Djulbegovic Benjamin, van Dalen Elvira C. Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviews Journal of clinical epidemiology 2019;108:1-9 [PubMed]
  • Clemens Eva, van den Heuvel-Eibrink Marry M., Mulder Renée L., Kremer Leontien C. M., Hudson Melissa M., Skinner Roderick, Constine Louis S., Bass Johnnie K., Kuehni Claudia E., Langer Thorsten, van Dalen Elvira C., Bardi Edith, Bonne Nicolas-Xavier, Brock Penelope R., Brooks Beth, Carleton Bruce, Caron Eric, Chang Kay W., Johnston Karen, Knight Kristin, Nathan Paul C., Orgel Etan, Prasad Pinki K., Rottenberg Jan, Scheinemann Katrin, de Vries Andrica C. H., Walwyn Thomas, Weiss Annette, am Zehnhoff-Dinnesen Antoinette, Cohn Richard J., Landier Wendy Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium lancet oncology 2019;20 (1):e29-e41
  • Feijen E. A. M. Lieke, Font-Gonzalez Anna, van der Pal Helena J. H., Kok Wouter E. M., Geskus Ronald B., Ronckers C. cile M., Bresters Dorine, van Dalen Elvira C., van Dulmen-den Broeder Eline, van den Berg Marleen H., van der Heiden-van der Loo Margriet, van den Heuvel-Eibrink Marry M., van Leeuwen Flora E., Loonen Jacqueline J., Neggers Sebastian J. C. M. M., Versluys A. B. Birgitta, Tissing Wim J. E., Kremer Leontien C. M. Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study Journal of the American Heart Association 2019;8 (1):e009122 [PubMed]

2018

  • Armenian Saro H., Armstrong Gregory T., Aune Gregory, Chow Eric J., Ehrhardt Matthew J., Ky Bonnie, Moslehi Javid, Mulrooney Daniel A., Nathan Paul C., Ryan Thomas D., van der Pal Helena J., van Dalen Elvira C., Kremer Leontien C. M. Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention Journal of clinical oncology 2018;36 (21):2135-2144 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Different infusion durations for preventing platinum-induced hearing loss in children with cancer: Version published: 05 July 2018 Cochrane database of systematic reviews (Online) 2018;2018 (7) [PubMed]
  • Loeffen Erik A. H., van Dalen Elvira C., Mulder Renée L., van de Wetering Marianne D., Kremer Leontien C. M., Tissing Wim J. E. The duration of anthracycline infusion should be at least one hour in children with cancer: A clinical practice guideline Pediatric blood & cancer 2018;65 (2):e26867 [PubMed]

2017

  • Rensen Niki, Gemke Reinoud J. B. J., van Dalen Elvira C., Rotteveel Joost, Kaspers Gertjan J. L. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia Cochrane database of systematic reviews (Online) 2017;2017 (11):CD008727 [PubMed]
  • Kraal Kathelijne C. J. M., van Dalen Elvira C., Tytgat Godelieve A. M., van Eck-Smit Berthe L. F. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma Cochrane database of systematic reviews (Online) 2017;2017 (4):CD010349 [PubMed]
  • Peinemann Frank, van Dalen Elvira C., Enk Heike, Berthold Frank Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation Cochrane database of systematic reviews (Online) 2017;2017 (8):CD010685 [PubMed]

2016

  • van Dalen Elvira C., van der Pal Helena J. H., Kremer Leontien C. M. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy Cochrane database of systematic reviews (Online) 2016;2016 (3):CD005008 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Different infusion durations for preventing platinum-induced hearing loss in children with cancer Cochrane database of systematic reviews (Online) 2016;2016 (8):CD010885 [PubMed]
  • Breunis Willemijn B., Haveman Lianne M., Vaarwerk Bas, Owers Emilia C., van Rijn Rick R., van den Berg Henk, Cohen Jérémie F., Kremer Leontien C. M. , van Dalen Elvira C., Merks Johannes H. M. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung and lymph node metastases in rhabdomyosarcoma Cochrane database of systematic reviews (Online) 2016 (8)
  • Feijen Elizabeth A. M., Font-Gonzalez Anna, van Dalen Elvira C., van der Pal Helena J. H., Reulen Raoul C., Winter David L., Kuehni Claudia E., Haupt Riccardo, Alessi Daniela, Byrne Julianne, Bardi Edit, Jakab Zsuzsanna, Grabow Desiree, Garwicz Stanislaw, Jankovic Momcilo, Levitt Gill A., Skinner Roderick, Zadravec Zaletel Lorna, Hjorth Lars, Tissing Wim J. E., de Vathaire Florent, Hawkins Mike M., Kremer Leontien C. M. Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup PLoS ONE 2016;11 (9):e0162778 [PubMed]
  • van Dalen Elvira C., Mank Arno, Leclercq Edith, Mulder Renée L., Davies Michelle, Kersten Marie José, van de Wetering Marianne D. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia Cochrane database of systematic reviews (Online) 2016;2016 (4):CD006247 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer Cochrane database of systematic reviews (Online) 2016;2016 (9):CD009219 [PubMed]
  • Cheuk Daniel K. L., Sieswerda Elske, van Dalen Elvira C., Postma Aleida, Kremer Leontien C. M. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer Cochrane database of systematic reviews (Online) 2016;2016 (8):CD008011 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Platinum-induced hearing loss after treatment for childhood cancer Cochrane database of systematic reviews (Online) 2016;2016 (8):CD010181 [PubMed]
  • Peinemann F., van Dalen E. C., Berthold F. Rapid COJEC Induction Therapy for High-risk Neuroblastoma Patients - Cochrane Review Rapid COJEC Induktionstherapie bei Hochrisiko-Patienten mit Neuroblastom - Cochrane Review Klinische Padiatrie 2016;228 (3):130-134 [PubMed]
  • Peinemann F., van Dalen E. C., Berthold F. Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation - Cochrane Review Retinsäure nach erfolgter autologer Stammzelltransplantation bei Hochrisiko-Patienten mit Neuroblastom - Cochrane Review Klinische Padiatrie 2016;228 (3):124-129 [PubMed]
  • van Dijk Irma W. E. M., van der Pal Helena J. H., van Os Rob M., Roos Yvo B. W. E. M., Sieswerda Elske, van Dalen Elvira C., Ronckers Cécile M., Oldenburger Foppe, van Leeuwen Flora E., Caron Huib N., Koning Caro C. E., Kremer Leontien C. M. Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis International journal of radiation oncology, biology, physics 2016;96 (3):597-605 [PubMed]

2015

  • Bleeker Gitta, Tytgat Godelieve A. M., Adam Judit A., Caron Huib N., Kremer Leontien C. M., Hooft Lotty, van Dalen Elvira C. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma Cochrane database of systematic reviews (Online) 2015;2015 (9):CD009263 [PubMed]
  • Aminkeng Folefac, Bhavsar Amit P., Visscher Henk, Rassekh Shahrad R., Li Yuling, Lee Jong W., Brunham Liam R., Caron Huib N., van Dalen Elvira C., Kremer Leontien C., van der Pal Helena J., Amstutz Ursula, Rieder Michael J., Bernstein Daniel, Carleton Bruce C., Hayden Michael R., Ross Colin J. D., MacLeod Stuart, Smith Anne, Hildebrand Claudette, Ghannadan Reza, Miao Fudan, Higginson Michelle, Massah Nasim, Borrie Adrienne, Hughes Shevaun, Shaw Kaitlyn, Dhoot Satvir, Kowalec Kaarina, Stortz Jessica, Bendyshe-Walton Tessa, Waltrip Duncan, Bader Rachel, Nijssen-Jordan Cheri, Johnson David, Verbeek Linda, Kaczowka Rick, Stevenson Patti, Zhuwaki Carnation, Grundy Paul, Stobart Kent, Wilson Bev, Desai Sunil, Spavor Maria, Churcher Linda, Chow Terence, Hall Kevin, Honcharik Nick, Israels Sara, Chan Shanna A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer Nature genetics 2015;47 (9):1079-1084 [PubMed]
  • Michiels Erna M. C., Schouten-van Meeteren Antoinette Y. N., Doz François, Janssens Geert O., van Dalen Elvira C. Chemotherapy for children with medulloblastoma Cochrane database of systematic reviews (Online) 2015;2015 (1):CD006678 [PubMed]
  • Mulder Renée L., Paulides Marios, Langer Thorsten, Kremer Leontien C. M., van Dalen Elvira C. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients Cochrane database of systematic reviews (Online) 2015;2015 (9):CD006300 [PubMed]
  • Kremer Leontien C. M., van Dalen Elvira C. Dexrazoxane in Children With Cancer: From Evidence to Practice Journal of clinical oncology 2015;33 (24):2594-2596 [PubMed]
  • Visscher Henk, Rassekh S. Rod, Sandor George S., Caron Huib N., van Dalen Elvira C., Kremer Leontien C., van der Pal Helena J., Rogers Paul C., Rieder Michael J., Carleton Bruce C., Hayden Michael R., Ross Colin J., Hayden Michael, Carleton Bruce, Ross Colin, MacLeod Stuart, Wasserman Wyeth, Mitton Craig, Smith Anne, Hildebrand Claudette, Pastrana Lucila Castro, Ghannadan Reza, Rassekh Rod, Miao Fudan, Higginson Michelle, Borrie Adrienne, Amstutz Ursula, Bhavsar Amit, Nijssen-Jordan Cheri, Johnson David, Verbeek Linda, Kaczowka Rick, Grundy Paul, Stobart Kent, Wilson Bev, Desai Sunil, Spavor Maria, Churcher Linda, Chow Terence, Hall Kevin, Honcharik Nick, Israels Sara, Chan Shanna, Garnham Byron, Staub Michelle, Rieder Michael, Malkin Becky, Portwine Carol, Cranston Amy, Koren Gideon Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children Pharmacogenomics 2015;16 (10):1065-1076 [PubMed]
  • Yalçin Bilgehan, Kremer Leontien C. M., van Dalen Elvira C. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma Cochrane database of systematic reviews (Online) 2015;2015 (10):CD006301 [PubMed]
  • Gordijn Maartje S., Rensen Niki, Gemke Reinoud J. B. J., van Dalen Elvira C., Rotteveel Joost, Kaspers Gertjan J. L. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia Cochrane database of systematic reviews (Online) 2015;2015 (8):CD008727 [PubMed]
  • van Dalen Elvira C., de Lijster Manou S., Leijssen Lieve G. J., Michiels Erna M. C., Kremer Leontien C. M., Caron Huib N., Aronson Daniel C. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children Cochrane database of systematic reviews (Online) 2015;2015 (1):CD008403 [PubMed]
  • Peinemann Frank, Tushabe Doreen A., van Dalen Elvira C., Berthold Frank Rapid COJEC versus standard induction therapies for high-risk neuroblastoma Cochrane database of systematic reviews (Online) 2015;2015 (5):CD010774 [PubMed]
  • Armenian Saro H., Hudson Melissa M., Mulder Renee L., Chen Ming Hui, Constine Louis S., Dwyer Mary, Nathan Paul C., Tissing Wim J. E., Shankar Sadhna, Sieswerda Elske, Skinner Rod, Steinberger Julia, van Dalen Elvira C., van der Pal Helena, Wallace W. Hamish, Levitt Gill, Kremer Leontien C. M. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group lancet oncology 2015;16 (3):E123-E136 [PubMed]
  • Peinemann Frank, van Dalen Elvira C., Tushabe Doreen A., Berthold Frank Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation Cochrane database of systematic reviews (Online) 2015;2015 (1):CD010685 [PubMed]
  • van der Pal Helena J., van Dijk Irma W., Geskus Ronald B., Kok Wouter E., Koolen Marianne, Sieswerda Elske, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Caron Huib N., Kremer Leontien C., van Dalen Elvira C. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study International journal of radiation oncology, biology, physics 2015;91 (1):213-222 [PubMed]

2014

  • Feijen Elizabeth Lieke A. M., van der Pal Helena J., van Dalen Elvira C., Mulder Renee L., Bardi Edit, Kuehni Claudia, Tissing Wim J. E., Kremer Leontine C. M. A new method to facilitate valid and consistent grading cardiac events in childhood cancer survivors using medical records PLoS ONE 2014;9 (7):e100432 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Different infusion durations for preventing platinum-induced hearing loss in children with cancer Cochrane database of systematic reviews (Online) 2014;2014 (6):CD010885 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer Cochrane database of systematic reviews (Online) 2014;2014 (7):CD009219 [PubMed]
  • van Dalen Elvira C., Raphaël Martine F., Caron Huib N., Kremer Leontien C. M. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer Cochrane database of systematic reviews (Online) 2014;2014 (9):CD006647 [PubMed]

2013

  • Schoot Reineke A., van Dalen Elvira C., van Ommen Cornelia H., van de Wetering Marianne D. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer Cochrane database of systematic reviews (Online) 2013;2013 (6):CD008975 [PubMed]
  • Mulder Renée L., Knijnenburg Sebastiaan L., Geskus Ronald B., van Dalen Elvira C., van der Pal Helena J. H., Koning Caro C. E., Bouts Antonia H., Caron Huib N., Kremer Leontien C. M. Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study Cancer epidemiology, biomarkers & prevention 2013;22 (10):1736-1746 [PubMed]
  • Yalcin Bilgehan, Kremer Leontien Cm, Caron Huib N., van Dalen Elvira C. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma Cochrane database of systematic reviews (Online) 2013;2013 (8):CD006301 [PubMed]
  • Mulder Renée L. Optimization of care for survivors of childhood cancer 2013. 268p. ISBN 9789461084026. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Caron H. N.; Co-supervisors: Kremer L. C. M., van Dalen E. C.)
  • Mulder Renée L., Kremer Leontien C. M., Koot Bart G. P., Benninga Marc A., Knijnenburg Sebastiaan L., van der Pal Helena J. H., Koning Caro C. E., Oldenburger Foppe, Wilde James C. H., Taminiau Jan A. J. M., Caron Huib N., van Dalen Elvira C. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors European journal of cancer (Oxford, England 2013;49 (1):185-193 [PubMed]
  • Sieswerda E., Mulder R. L., van Dijk I. W. E. M., van Dalen E. C., Knijnenburg S. L., van der Pal H. J. H., Mud M. S., Heinen R. C., Caron H. N., Kremer L. C. M. The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability Journal of cancer survivorship 2013;7 (3):439-454 [PubMed]
  • Knops R. R. G., van Dalen E. C., Mulder R. L., Leclercq E., Knijnenburg S. L., Kaspers G. J. L., Pieters R., Caron H. N., Kremer L. C. M. The volume effect in paediatric oncology: a systematic review Annals of oncology 2013;24 (7):1749-1753 [PubMed]
  • Leclercq Edith, Leeflang Mariska M. G., van Dalen Elvira C., Kremer Leontien C. M. Validation of search filters for identifying pediatric studies in PubMed Journal of pediatrics 2013;162 (3):629-634.e2 [PubMed]
  • Visscher H., Ross C. J. D., Rassekh S. R., Sandor G. S. S., Caron H. N., van Dalen E. C., Kremer L. C., van der Pal H. J., Rogers P. C., Rieder M. J., Carleton B. C., Hayden M. R., Hayden Michael, Carleton Bruce, Ross Colin, MacLeod Stuart, Wasserman Wyeth, Mitton Craig, Smith Anne, Hildebrand Claudette, Pastrana Lucila Castro, Ghannadan Reza, Rassekh Rod, Lim Jonathan, Carter Catherine, Miao Fudan, Visscher Henk, Pussegoda Kusala, Higginson Michelle, Butland Stefanie, Yazdanpanah Mojgan, Nijssen-Jordan Cheri, Johnson David, Verbeek Linda, Kaczowka Rick, Stevenson Patti, Grundy Paul, Stobart Kent, Wilson Bev, Desai Sunil, Spavor Maria, Churcher Linda, Chow Terence, Hall Kevin, Honcharik Nick, Israels Sara, Chan Shanna, Garnham Byron, Staub Michelle, Rieder Michael Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children Pediatric blood & cancer 2013;60 (8):1375-1381 [PubMed]

2012

  • Mulder Renée L., Paulides Marios, Langer Thorsten, Kremer Leontien C. M., van Dalen Elvira C. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients Cochrane database of systematic reviews (Online) 2012;2012 (12):CD006300 [PubMed]
  • van der Pal Helena J., van Dalen Elvira C., van Delden Evelien, van Dijk Irma W., Kok Wouter E., Geskus Ronald B., Sieswerda Elske, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Caron Huib N., Kremer Leontien C. High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors Journal of clinical oncology 2012;30 (13):1429-1437 [PubMed]
  • Gordijn Maartje S., Gemke Reinoud J. B. J., van Dalen Elvira C., Rotteveel Joost, Kaspers Gertjan J. L. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia Cochrane database of systematic reviews (Online) 2012;2012 (5):CD008727 [PubMed]
  • van Dalen Elvira C., Mank Arno, Leclercq Edith, Mulder Renée L., Davies Michelle, Kersten Marie José, van de Wetering Marianne D. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia Cochrane database of systematic reviews (Online) 2012;2012 (9):CD006247 [PubMed]
  • van As Jorrit W., van den Berg Henk, van Dalen Elvira C. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer Cochrane database of systematic reviews (Online) 2012;2012 (5):CD009219 [PubMed]
  • de Lijster Manou S., Bergevoet Rosemarijn M., van Dalen Elvira C., Michiels Erna M. C., Caron Huib N., Kremer Leontien C. M., Aronson Daniel C. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children Cochrane database of systematic reviews (Online) 2012;2012 (1):CD008403 [PubMed]
  • Visscher Henk, Ross Colin J. D., Rassekh S. Rod, Barhdadi Amina, Dubé Marie-Pierre, Al-Saloos Hesham, Sandor George S., Caron Huib N., van Dalen Elvira C., Kremer Leontien C., van der Pal Helena J., Brown Andrew M. K., Rogers Paul C., Phillips Michael S., Rieder Michael J., Carleton Bruce C., Hayden Michael R., Dube Marie-Pierre Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children Journal of clinical oncology 2012;30 (13):1422-1428 [PubMed]
  • Sieswerda E., Postma A., van Dalen E. C., van der Pal H. J. H., Tissing W. J. E., Rammeloo L. A. J., Kok W. E. M., van Leeuwen F. E., Caron H. N., Kremer L. C. M. The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors Annals of oncology 2012;23 (8):2191-2198 [PubMed]

2011

  • van der Pal Helena J., van Dalen Elvira C., Hauptmann Michael, Kok Wouter E., Caron Huib N., van den Bos Cor, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Kremer Leontien C. Cardiac Function in 5-Year Survivors of Childhood Cancer Reply Archives of internal medicine 2011;171 (3):264-265
  • van Dalen Elvira C., Caron Huib N., Dickinson Heather O., Kremer Leontien C. M. Cardioprotective interventions for cancer patients receiving anthracyclines Cochrane database of systematic reviews (Online) 2011;2011 (6):CD003917 [PubMed]
  • Mulder Renée L., van Dalen Elvira C., van den Hof Malon, Bresters Dorine, Koot Bart G. P., Castellino Sharon M., Loke Yoon, Leclercq Edith, Post Piet N., Caron Huib N., Postma Aleida, Kremer Leontien C. M. Hepatic late adverse effects after antineoplastic treatment for childhood cancer Cochrane database of systematic reviews (Online) 2011;2011 (7):CD008205 [PubMed]
  • Sieswerda Elske, van Dalen Elvira C., Postma Aleida, Cheuk Daniel Kl, Caron Huib N., Kremer Leontien C. M. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer Cochrane database of systematic reviews (Online) 2011;2011 (9):CD008011 [PubMed]
  • van Dalen Elvira C., van As Jorrit W., de Camargo Beatriz Methotrexate for high-grade osteosarcoma in children and young adults Cochrane database of systematic reviews (Online) 2011;2011 (5):CD006325 [PubMed]
  • van Dalen Elvira C., van den Berg Henk, Raphaël Martine F., Caron Huib N., Kremer Leontien C. Should anthracyclines and dexrazoxane be used for children with cancer? lancet oncology 2011;12 (1):12-13 [PubMed]
  • Sieswerda E., Kremer L. C. M., Caron H. N., van Dalen E. C. The use of liposomal anthracycline analogues for childhood malignancies: A systematic review European journal of cancer (Oxford, England 2011;47 (13):2000-2008 [PubMed]
  • van Dalen Elvira C., Raphael Martine F., Caron Huib N., Kremer Leontien Cm Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer Cochrane database of systematic reviews (Online) 2011;2011 (1):CD006647 [PubMed]

2010

  • van der Pal Helena J., van Dalen Elvira C., Hauptmann Michael, Kok Wouter E., Caron Huib N., van den Bos Cor, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Kremer Leontien C. Cardiac Function in 5-Year Survivors of Childhood Cancer A Long-term Follow-up Study Archives of internal medicine 2010;170 (14):1247-1255 [PubMed]
  • Mulder Renée L., Paulides Marios, Langer Thorsten, Kremer Leontien C. M., van Dalen Elvira C. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients Cochrane database of systematic reviews (Online) 2010;2010 (2):CD006300 [PubMed]
  • van Dalen Elvira C., Michiels Erna M. C., Caron Huib N., Kremer Leontien C. M. Different anthracycline derivates for reducing cardiotoxicity in cancer patients Cochrane database of systematic reviews (Online) 2010;2010 (3):CD005006 [PubMed]
  • van Dalen Elvira C., Michiels Erna M. C., Caron Huib N., Kremer Leontien C. M. Different anthracycline derivates for reducing cardiotoxicity in cancer patients Cochrane database of systematic reviews (Online) 2010;2010 (5):CD005006 [PubMed]
  • Yalçin Bilgehan, Kremer Leontien C. M., Caron Huib N., van Dalen Elvira C. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma Cochrane database of systematic reviews (Online) 2010;2010 (5):CD006301 [PubMed]
  • de Lijster Manou S., Bergevoet Rosemarijn M., van Dalen Elvira C., Michiels Erna M. C., Caron Huib N., Kremer Leontien C. M., Aronson Daniel C. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children Cochrane database of systematic reviews (Online) 2010;2010 (3):CD008403 [PubMed]
  • van Dalen Elvira C., Mulder Renée L., Caron Huib N., Kremer Leontien C. M. Response to "Cancer care in the pediatric surgical patient: A paradigm to abolish volume-outcome disparities in surgery" Surgery 2010;147 (2):310-311 [PubMed]

2009

  • van Dalen Elvira C., van der Pal Helena J. H., Caron Huib N., Kremer Leontien C. M. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy Cochrane database of systematic reviews (Online) 2009;2009 (4):CD005008 [PubMed]
  • van Dalen Elvira C., Kremer Leontien C. M. Employment status among cancer survivors JAMA 2009;302 (1):33-4; author reply 34-5 [PubMed]
  • van Dalen Elvira C., de Camargo Beatriz Methotrexate for high-grade osteosarcoma in children and young adults Cochrane database of systematic reviews (Online) 2009;2009 (1):CD006325 [PubMed]
  • ten Bruggencate M. J. M., Kremer L. C. M., Caron H. N., Knops A. M., van Dalen E. C. Pediatric oncologists and evidence-based medicine: A postal survey in The Netherlands Pediatric blood & cancer 2009;52 (2):231-236 [PubMed]
  • Mulder Renée L., Kremer Leontien C. M., van Santen Hanneke M., Ket Jan Lucas, van Trotsenburg A. S. Paul, Koning Caro C. E., Schouten-van Meeteren Antoinette Y. N., Caron Huib N., Neggers Sebastian J. C. M. M., van Dalen Elvira C. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic review Cancer treatment reviews 2009;35 (7):616-632 [PubMed]
  • Lundh Andreas, Knijnenburg Sebastiaan L., Jørgensen Anders W., van Dalen Elvira C., Kremer Leontien C. M. Quality of systematic reviews in pediatric oncology - A systematic review Cancer treatment reviews 2009;35 (8):645-652 [PubMed]
  • van Dalen Elvira C., Raphaël Martine F., Caron Huib N., Kremer Leontien C. M. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer Cochrane database of systematic reviews (Online) 2009;2009 (1):CD006647 [PubMed]

2008

  • van Dalen E. C., Caron H. N., Dickinson H. O., Kremer L. C. M. Cardioprotective interventions for cancer patients receiving anthracyclines Cochrane database of systematic reviews (Online) 2008;2008 (2):CD003917 [PubMed]

2007

  • van Dalen Elvira C. Anthracycline-induced cardiotoxicity during and after treatment for childhood cancer. Long-term risk, risk factors and prevention 2007. 262p. ISBN 9789090214047. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Caron Huib N.; Co-supervisor: Kremer Leontien C. M.)
  • van Dalen Elvira C. Anthracycline-induced heart failure Nature clinical practice. Oncology 2007;4 (12):E1 [PubMed]
  • van Dalen Elvira C., Caron Huib N., Kremer Leontien C. M. Prevention of anthracycline-induced cardiotoxicity in children: the evidence European journal of cancer (Oxford, England 2007;43 (7):1134-1140 [PubMed]

2006

  • van Dalen Elvira C., van den Brug Marieke, Caron Huib N., Kremer Leontien C. M. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials European journal of cancer (Oxford, England 2006;42 (18):3199-3205 [PubMed]
  • Kremer L. C. M., van der Pal H. J. H., Postma A., van Dalen E. C. Cardiotoxiteit van antracyclines Bijblijven 2006;22 (8):37-40
  • van Dalen Elvira C., van der Pal Helena J. H., van den Bos Cor, Kok Wouter E. M., Caron Huib N., Kremer Leontien C. M. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines European journal of cancer (Oxford, England 2006;42 (15):2549-2553 [PubMed]
  • van Dalen Elvira C., van der Pal Helena J. H., Kok Wouter E. M., Caron Huib N., Kremer Leontien C. M. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study European journal of cancer (Oxford, England 2006;42 (18):3191-3198 [PubMed]
  • van Dalen E. C., Michiels E. M. C., Caron H. N., Kremer L. C. M. Different anthracycline derivates for reducing cardiotoxicity in cancer patients Cochrane database of systematic reviews (Online) 2006;2006 (4):CD005006 [PubMed]
  • van Dalen E. C., van der Pal H. J. H., Caron H. N., Kremer L. C. M. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy Cochrane database of systematic reviews (Online) 2006;2006 (4):CD005008 [PubMed]

2005

  • van Dalen E. C., Caron H. N., Dickinson H. O., Kremer L. C. M. Cardioprotective interventions for cancer patients receiving anthracyclines Cochrane database of systematic reviews (Online) 2005;2005 (1):CD003917.pub2 [PubMed]
  • van Dalen Elvira C., van der Pal Heleen J. H., Reitsma Johannes B., de Winter Robbert J., Helbing Wim A., Ottenkamp Jaap, Caron Huib N., Kremer Leontien C. M. Management of asymptomatic anthracycline-induced cardiac damage after treatment for childhood cancer - A postal survey among dutch adult and pediatric cardiologists Journal of pediatric hematology/oncology 2005;27 (6):319-322 [PubMed]
  • van der Pal Helena J. H., van Dalen Elvira C., Kremer Leontien C. M., Bakker Piet J. M., van Leeuwen Flora E. Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: A systematic review Cancer treatment reviews 2005;31 (3):173-185 [PubMed]

2004

  • van Dalen E. C., van der Pal H. J. H., Bakker P. J. M., Caron H. N., Kremer L. C. M. Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review European journal of cancer (Oxford, England 2004;40 (5):643-652 [PubMed]
  • van Dalen E. C., van der Pal H. J. H., Kremer L. C. M. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy Cochrane database of systematic reviews (Online) 2004;2004 (3):CD005008

2003

  • van Dalen E. C., van der Pal H. J. H., van den Bos C., Caron H. N., Kremer L. C. M. Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: The need for evidence Journal of clinical oncology 2003;21 (17):3377-3377; author reply 3378 [PubMed]

2002

  • Kremer L. C. M., van Dalen E. C., Offringa M., Voûte P. A. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review Annals of oncology 2002;13 (4):503-512 [PubMed]
  • Kremer L. C. M., van der Pal H. J. H., Offringa M., van Dalen E. C., Voûte P. A. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review Annals of oncology 2002;13 (6):819-829 [PubMed]
  • van Dalen E. C., Kremer L. C. M., Offringa M., Ottenkamp J., Voûte P. A. Klinisch hartfalen na behandeling met antracyclinederivaten: incidentie en risicofactoren onder 607 kinderen met kanker Nederlands tijdschrift voor geneeskunde 2002;146 (16):761

2001

  • Kremer L. C., van Dalen E. C., Offringa M., Ottenkamp J., Voûte P. A. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study Journal of clinical oncology 2001;19 (1):191-196 [PubMed]